Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Critical Reviews™ in Eukaryotic Gene Expression
Fator do impacto: 1.841 FI de cinco anos: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN Imprimir: 1045-4403
ISSN On-line: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.2016015964
pages 137-142

The Impacts of miRNAs in Glioblastoma Progression

Rasime Kalkan
Near East University, Faculty of Medicine, Department of Medical Genetics, Cyprus
Emine İkbal Atli
Department of Medical Genetics, Faculty of Medicine, Trakya University, Edirne, Turkey


miRNAs are short noncoding RNA sequences that cause translational repression or mRNA degradation. A growing number of studies have sought new biomarkers in GBM that will be important in disease progression and prognosis and as potential therapeutic targets. miRNA-profiling studies in glioblastoma patients have found that aberrant miRNA expression can be used as a target to develop new biomarkers for disease detection and for determining prognosis or therapeutic response. In evaluating the tumor or its therapeutic response, genetic abnormalities such as mutations, epigenetic abnormalities, and aberrant miRNA expressions can be useful markers. This review summarizes the known miRNAs according their therapeutic importance and their use as disease progression biomarkers.

Palavras-chave: miRNA, GBM, Glioblastoma, therapy, survival

Articles with similar content:

MicroRNAs as New Diagnostic and Prognostic Biomarkers in Urological Tumors
Critical Reviews™ in Oncogenesis, Vol.18, 2013, issue 4
Klaus Jung, Annika Fendler
From Molecular Tumor Diagnostics to Individualized Treatment with Phytochemicals Derived from Chinese Herbs
Forum on Immunopathological Diseases and Therapeutics, Vol.2, 2011, issue 4
Thomas Efferth
Monogenic and Complex Forms of Obesity: Insights from Genetics Reveal the Leptin-Melanocortin Signaling Pathway as a Common Player
Critical Reviews™ in Eukaryotic Gene Expression, Vol.22, 2012, issue 4
Sigri Beckers, Doreen Zegers, Luc F. Van Gaal, Wim Van Hul
Homeobox Gene Involvement in Normal Hematopoiesis and in the Pathogenesis of Childhood Leukemias
Critical Reviews™ in Oncogenesis, Vol.22, 2017, issue 3-4
Vassilis Zoumpourlis, Ioannis Christodoulou, Maria Adamaki, Maria Goulielmaki, Spiros Vlahopoulos
miRNA in Hepatocellular Carcinoma: Pathogenesis and Therapeutic Approaches
Critical Reviews™ in Eukaryotic Gene Expression, Vol.27, 2017, issue 4
Muhammad Imran Qadir, Samana Zahra Rizvi